The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries

Abstract

Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise, the unique design constraints presented in low-resource settings, coupled with the variety of country-specific regulatory and institutional dynamics, have made it difficult for investigators to translate successful POC cancer interventions to the LMIC markets. In response to this need, the National Cancer Institute has partnered with the National Institute of Biomedical Imaging and Bioengineering to create the National Institutes of Health Affordable Cancer Technologies (ACTs) program. This program seeks to simplify the pathway to market by funding multidisciplinary investigative teams to adapt and validate the existing technologies for cancer detection, diagnosis, and treatment in LMIC settings. The various projects under ACTs range from microfluidic cancer diagnostic tools to novel treatment devices, each geared for successful clinical adaptation to LMIC settings. Via progression through this program, each POC innovation will be uniquely leveraged for successful clinical translation to LMICs in a way not before seen in this arena.

The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary

“…Although relatively low-cost, gas-based systems present significant challenges due to difficulties with safely procuring and transporting gas tanks to remote areas to support mobile screen-and-treat efforts. CryoPop, a modified gas-based system, uses CO 2 gas at one tenth the amount of a traditional system per treatment, solving portability but not procurement challenges [104] . CryoPen ( Figure 3 ), originally created for dermatologic lesions, has been adapted as a non-gas-based cryotherapy tool.…”

The Promise of Clinical Decision Support Systems Targetting Low-Resource Settings

“…The National Institutes of Health recently set up the Af-fordable Health Technologies program in effort to reduce the burden of cancer in low and middle income countries. The work by Pearlman et al [126] sheds light on promising cancer detection and diagnosis work already taking place globally. Hunt et al [123] conducted a prospective randomized trial evaluating the performance of al algorithm designed to identify neoplastic processes from microscopic pathology images.…”

Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute’s Center for Global Health

“…Working closely with other NCI divisions, NIH institutes, and NCI-designated cancer centers, NCI-CGH has developed and participated in research programs and initiatives that both promote cancer research and control and develop research underpinnings and networks to facilitate collaboration and increase efforts to address the global cancer burden, with emphasis on LMICs. 18 …”